These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 29603410)

  • 21. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study.
    Chinthrajah RS; Purington N; Andorf S; Long A; O'Laughlin KL; Lyu SC; Manohar M; Boyd SD; Tibshirani R; Maecker H; Plaut M; Mukai K; Tsai M; Desai M; Galli SJ; Nadeau KC
    Lancet; 2019 Oct; 394(10207):1437-1449. PubMed ID: 31522849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral peanut immunotherapy in children with peanut anaphylaxis.
    Blumchen K; Ulbricht H; Staden U; Dobberstein K; Beschorner J; de Oliveira LC; Shreffler WG; Sampson HA; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2010 Jul; 126(1):83-91.e1. PubMed ID: 20542324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of peanut oral immunotherapy-Real-life experience.
    Nachshon L; Goldberg MR; Katz Y; Levy MB; Elizur A
    Pediatr Allergy Immunol; 2018 Aug; 29(5):519-526. PubMed ID: 29698554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE.
    Tsai M; Mukai K; Chinthrajah RS; Nadeau KC; Galli SJ
    J Allergy Clin Immunol; 2020 Mar; 145(3):885-896.e6. PubMed ID: 31805311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and immune regulation with peanut oral immunotherapy.
    Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
    J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
    Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peanut Oral Immunotherapy: a Current Perspective.
    Patrawala M; Shih J; Lee G; Vickery B
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):14. PubMed ID: 32314071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful oral tolerance induction in severe peanut allergy.
    Clark AT; Islam S; King Y; Deighton J; Anagnostou K; Ewan PW
    Allergy; 2009 Aug; 64(8):1218-20. PubMed ID: 19226304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peanut allergy and oral immunotherapy.
    Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
    Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
    Yee CSK; Albuhairi S; Noh E; El-Khoury K; Rezaei S; Abdel-Gadir A; Umetsu DT; Burke-Roberts E; LeBovidge J; Schneider L; Rachid R
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):451-461.e7. PubMed ID: 30267889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low dose immunotherapy in very young children to treat peanut allergy.
    Vickery BP
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
    Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
    Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal.
    Marrs T; Flohr C; Perkin MR
    Br J Dermatol; 2015 Nov; 173(5):1125-9. PubMed ID: 26769642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse strain differences in response to oral immunotherapy for peanut allergy.
    Wagenaar L; Bol-Schoenmakers MWHC; Giustarini G; Garssen J; Smit JJ; Pieters RHH
    Immun Inflamm Dis; 2019 Mar; 7(1):41-51. PubMed ID: 30838819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey.
    Arkwright PD; MacMahon J; Koplin J; Rajput S; Cross S; Fitzsimons R; Davidson N; Deshpande V; Rao N; Lumsden C; Lacy D; Allen KJ; Vance G; Mwenechanya J; Fox AT; Erlewyn-Lajeunesse M; Mistry H; Hourihane JO
    Pediatr Allergy Immunol; 2018 Nov; 29(7):754-761. PubMed ID: 30022517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic and clinical responses to parenteral immunotherapy in peanut anaphylaxis--a study using IgE and IgG4 immunoblot monitoring.
    Bullock RJ; Barnett D; Howden ME
    Allergol Immunopathol (Madr); 2005; 33(5):250-6. PubMed ID: 16287543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy.
    Lloyd M; Loke P; Ashley S; Lozinsky AC; Orsini F; O'Sullivan M; Gold M; Quinn P; Metcalfe J; Tang MLK
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1019-1028.e2. PubMed ID: 38154554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
    Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
    Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study).
    Chebar Lozinsky A; Loke P; Orsini F; O'Sullivan M; L Prescott S; Gold MS; Quinn P; DunnGalvin A; Lk Tang M;
    BMJ Open; 2020 Sep; 10(9):e035871. PubMed ID: 32912942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.